Affimed N.V. (NASDAQ:AFMD) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET

Company Participants

Alex Fudukidis - Director of IR

Adi Hoess - CEO

Andreas Harstrick - Chief Medical Officer

Arndt Schottelius - Chief Scientific Officer

Wolfgang Fischer - COO

Angus Smith - CFO

Conference Call Participants

Srikripa Devarakonda - Truist

Maurice Raycroft - Jefferies

Daina Graybosch - SVB Securities

Do Kim - Piper Sandler

Li Watsek - Cantor

James Shin - Wells Fargo

Yale Jen - Laidlaw & Company

Zhiqiang Shu - Berenberg

Operator

Thank you for standing by. Welcome to today's Third Quarter Earnings and Business Update Conference Call by Affimed N.V. As a reminder, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. Please note this conference call is being recorded.

I would now like to hand the call over to your host for today, Alex Fudukidis, Director of Investor Relations at Affimed. Please go ahead.

Alex Fudukidis

Thank you, Shannon, and thank you all for joining us for our call today. Before we begin, I'd like to remind everyone that we issued the relevant press release earlier today, which can be found on the Investor Relations section of our website.

On the call today, we have members of our management team, including Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Wolfgang Fischer, Chief Operating Officer; Denise Mueller, our Chief Business Officer; and Angus Smith, our Chief Financial Officer. The team will be available for the Q&A session after the prepared remarks.

Before we start, I'd like to remind you that today's presentation contains projections and forward-looking statements regarding future events. These statements represent our beliefs and assumptions only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.

These forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in these statements due to various factors, including, but not limited to, those identified under the section entitled Risk Factors in our filings with the SEC and those identified under the section entitled Forward-Looking Statements in the press release that we issued today and filed with the SEC.